Lactobacillus priming of the respiratory tract: Heterologous immunity and protection against lethal pneumovirus infection

Antiviral Research

Volumn 97, Issue 3, 2013, Pages 270-279

  Garcia Crespo, Katia E ^a   Chan, Calvin C ^a   Gabryszewski, Stanislaw J ^a,c   Percopo, Caroline M ^a   Rigaux, Peter ^a,d   Dyer, Kimberly D ^a   Domachowske, Joseph B ^b   Rosenberg, Helene F ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b State University of New York Upstate Medical University: College of Medicine   (United States)

^c Columbia University College of Physicians and Surgeons ^*  (United States)

^d Tibotec BVBA Johnson and Johnston ^*  (Belgium)

Author keywords

Cytokines; Genomic DNA; Heterologous immunity; Neutrophils; Peptidoglycan

Indexed keywords

BACTERIAL DNA; CXCL1 CHEMOKINE; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GENOMIC DNA; INTERLEUKIN 17; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; PEPTIDOGLYCAN; PROBIOTIC AGENT; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL CLEARANCE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; INFECTION PREVENTION; LACTOBACILLUS PLANTARUM; LEUKOCYTE; LUNG INFECTION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PNEUMOVIRUS INFECTION; PRIORITY JOURNAL; TH1 CELL; VIRUS SURVIVAL;

ANIMALS; CYTOKINES; FEMALE; HUMANS; IMMUNITY; LACTOBACILLUS; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MURINE PNEUMONIA VIRUS; NEUTROPHILS; PNEUMOVIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUSES; RESPIRATORY SYSTEM;

LACTOBACILLUS; LACTOBACILLUS REUTERI; MURINE PNEUMONIA VIRUS; MUS; PNEUMOVIRUS; POTATO VIRUS M;

EID: 84871863623     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2012.12.022     Document Type: Article

References (55)

1. Ayala V.I., Teijaro J.R., Farber D.L., Dorsey S.G., Carbonetti N.H. Bordetella pertussis infection exacerbates influenza virus infection through pertussis toxin-mediated suppression of innate immunity. PLoS One 2011, 6(4):e10916.
2. Ballinger M.N., Standiford T.J. Postinfluenza bacterial pneumonia: host defenses gone awry. J. Interferon Cytokine Res. 2010, 30:643-652.
3. Bem R.A., Domachowske J.B., Rosenberg H.F. Animal models of human respiratory syncytial virus disease. Am. J. Physiol. Lung Cell Mol. Physiol. 2011, 201:L148-L156.
4. Biswas A., Petnicki-Ocwieja T., Kobayashi K.S. Nod2: a key regulator linking microbiota to intestinal mucosal immunity. J. Mol. Med. 2012, 90:15-24.
5. Bonville C.A., Easton A.J., Rosenberg H.F., Domachowske J.B. Altered pathogenesis of severe pneumovirus infection in response to combined antiviral and specific immunomodulatory agents. J. Virol. 2003, 77:1237-1244.
6. Bonville C.A., Lau V.K., DeLeon J.M., Gao J.L., Easton A.J., Rosenberg H.F., Domachowske J.B. Functional antagonism of chemokine receptor CCR1 reduces mortality in acute pneumovirus infection in vivo. J. Virol. 2004, 78:7984-7989.
7. Bouladoux N., Hall J.A., Grainger J.R., Dos Santos L.M., Kann M.G., Nagarajan V., Verthelyi D., Belkaid Y. Regulatory role of suppressive motifs from commensal DNA. Mucosal Immunol. 2012, 5:623-634.
8. Chagnaud P., Machinis K., Coutte L.A., Marecat A., Mercenier A. Rapid PCR-based procedure to identify lactic acid bacteria: application to six common Lactobacillus species. J. Microbiol. Methods 2001, 44:139-148.
9. Clement C.G., Evans S.E., Evans C.M., Hawke D., Kobayashi R., Reynolds P.R., Moghaddam S.J., Scott B.L., Melicoff E., Adachi R., Dickey B.F., Tuvim M.J. Am. J. Respir. Crit. Care Med. 2008, 177:1322-1330.
10. Coulombe F., Fiola S., Akira S., Cormier Y., Gosselin J. Muramyl-dipeptide induces NOD2-dependent Ly6C(high) monocyte recruitment to the lungs and protects against influenza virus infection. PLoS One 2012, 7:e36734.
11. Daley J.M., Thomay A.A., Connolly M.D., Reichner J.S., Albina J.E. Use of Ly6G-specific monoclonal antibody to deplete neutrophils in mice. J. Leukoc. Biol. 2008, 83:64-70.
12. Dalton D.K., Pitts-Meek S., Keshav S., Figari I.S., Bradley A., Stewart T.A. Multiple defects of immune cell function in mice with disrupted interferon-gamma genes. Science 1993, 259:1739-1742.
13. Davis K.M., Nakamura S., Weiser J.N. Nod2 sensing of lysozyme-digested peptidoglycan promotes macrophage recruitment and clearance of S. pneumonia colonization in mice. J. Clin. Invest. 2011, 121:3666-3676.
14. Didierlaurent A., Goulding J., Hussell T. The impact of successive infections on the lung microenvironment. Immunology 2007, 122:457-465.
15. Divangahi M., Mostowy S., Coulombe F., Kozak R., Guillot L., Veyrier F., Kobayashi K.S., Flavell R.A., Gros P., Behr M.A. NOD2-deficient mice have impaired resistance to Mycobacterium tuberculosis infection through defective innate and adaptive immunity. J. Immunol. 2008, 181:7157-7165.
16. Duggan J.M., You D., Cleaver J.O., Larson D.T., Garza R.J., GuzmanPruneda F.A., Tuvim M.J., Zhang J., Dickey B.F., Evans S.E. Synergistic interactions of TLR2/6 and TLR9 induce a high level of resistance to lung infection in mice. J. Immunol. 2011, 186:5916-5926.
17. Dyer K.D., Garcia-Crespo K.E., Glineur S., Domachowske J.B., Rosenberg H.F. The pneumonia virus of mice (PVM) model of acute respiratory infection. Viruses 2012, In review.
18. Erwin A.L., Smith A.L. Nontypeable Haemophilus influenzae: understanding virulence and commensal behavior. Trends Microbiol. 2007, 15:355-362.
19. Evans S.E., Xu Y., Tuvim M.J., Dickey B.F. Inducible innate resistance of lung epithelium to infection. Ann. Rev. Physiol. 2010, 72:413-435.
20. Evans S.E., Tuvim M.J., Fox C.J., Sachdev N., Gibiansky L., Dickey B.F. Inhaled innate immune ligands to prevent pneumonia. Brit. J. Pharmacol. 2011, 163:195-206.
21. Falsey A.R., Walsh E.E. Respiratory syncytial virus infection in elderly adults. Drugs Aging 2005, 22:577-587.
22. Foxwell A.R., Kyd J.M., Cripps A.W. Nontypeable Haemophilus influenzae: pathogenesis and prevention. Microbiol. Mol. Biol. Rev. 1998, 62:294-308.
23. Frutuoso M.S., Hori J.I., Pereira M.S., Junior D.S., Sonego F., Kobayashi K.S., Flavell R.S., Cunha F.Q., Zamboni D.S. The pattern recognition receptors Nod1 and Nod2 account for neutrophil recruitment to the lungs of mice infected with Legionella pneumophila. Microbes Infect. 2010, 12:819-827.
24. Gabryszewski S.J., Bachar O., Dyer K.D., Percopo C.M., Killoran K.E., Domachowske J.B., Rosenberg H.F. Lactobacillus-mediated priming of the respiratory mucosa protects against lethal pneumovirus infection. J. Immunol. 2011, 186:1151-1161.
25. Goulding J., Snelgrove R., Saldana J., Didierlaurent A., Cavanagh M., Gwyer E., Wales J., Wissinger E.L., Hussell T. Respiratory virus infections: do we ever recover?. Proc. Am. Thorac. Soc. 2007, 4:618-625.
26. Haarman M., Knol J. Quantitative real-time PCR analysis of fecal Lactobacillus species in infants receiving a prebiotic infant formula. Appl. Environ. Microbiol. 2006, 72:2359-2365.
27. Hahn I., Klaus A., Janze A.K., Steinwede K., Ding N., Bohling J., Brumshagen C., Serrano H., Gauthier F., Paton J.C., Welte T., Maus U.A. Cathepsin G and neutrophil elastase play critical and nonredundant roles in lung-protective immunity against Streptococcus pneumoniae in mice. Infect. Immun. 2011, 79:4893-4901.
28. Hall C.B., Weinberg G.A., Iwane M.K., Blumkin A.K., Edwards K.M., Staat M.A., Auinger P., Griffin M.R., Poehling K.A., Erdman D., Grijalva C.G., Zhu Y., Szilagyi P. The burden of respiratory syncytial virus infection in young children. N. Engl. J. Med. 2009, 360:588-598.
29. Harata G., He F., Hiruta N., Kawase M., Kubota A., Hiramatsu M., Yausi H. Intranasal administration of Lactobacillus rhamnosus GG protects mice from H1N1 influenza virus infection by regulating respiratory immune responses. Lett. Appl. Microbiol. 2010, 50:597-602.
30. Hori T., Kiyoshima J., Shida K., Yasui H. Effect of intranasal administration of Lactobacillus casei Shirota on influenza infection of the upper respiratory tract in mice. Clin. Diag. Lab. Immunol. 2001, 8:593-597.
31. Hussell T., Cavanagh M.M. The innate immune rheostat: influence on lung inflammatory disease and secondary bacterial pneumonia. Biochem. Soc. Trans. 2009, 37:811-813.
32. Inada K., Takahashi K., Ichinohe S., Suda H., Tsuchiya M., Takahashi J., Matsuura S., Kasai T., Yoshida M., Endo S., Sato S. A silkworm larvae plasma test for detecting peptidoglycan in cerebrospinal fluid is useful for the diagnosis of bacterial meningitis. Microbiol. Immunol. 2003, 47:701-707.
33. Izumo T., Maekawa T., Ida M., Noguchi A., Kitagawa Y., Shibata H., Yasui H., Kiso Y. Effect of intranasal administration of Lactobacillus pentosus S-PT84 on influenza virus infection in mice. Int. Immunopharmacol. 2010, 10:1101-1106.
34. Kim C.H., Kim H.G., Kim J.Y., Kim N.F., Jung B.J., Jeong J.H., Chung D.K. Probiotic genomic DNA reduces the production of pro-inflammatory cytokine tumor necrosis factor-alpha. FEMS Microbiol. Lett. 2012, 328:13-19.
35. Leckie M.J., et al. Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response. Lancet 2000, 356:2144-2148.
36. Li R., Lim A., Phoon M.C., Narasaraju T., Ng J.K., Poh W.P., Sim M.K., Chow V.T., Locht C., Alonso S. Attenuated Bordetella pertussis protects against highly pathogenic influenza A viruses by dampening the cytokine storm. J. Virol. 2010, 84:7105-7113.
37. Macho Fernandez E., Valenti V., Rockel C., Hermann C., Pot B., Boneca I.G., Grangette C. Anti-inflammatory capacity of selected lactobacilli in experimental colitis is driven by NOD2-mediated recognition of a specific peptidoglycan-derived muropeptide. Gut 2011, 60:1050-1059.
38. McFarlane E., Perez C., Charmoy M., Allenbach C., Carter K.C., Alexander J., Tacchini-Cottier F. Neutrophils contribute to development of a protective immune response during onset of infection with Leishmania donovani. Infect. Immun. 2008, 76:532-541.
39. Nguyen Y., McGuffie B.A., Anderson V.E., Weinberg J.B. Gammaherpes virus modulation of mouse adenovirus type 1 pathogenesis. Virology 2008, 380:182-190.
40. Pappu R., Rutz S., Ouyang W. Regulation of epithelial immunity by IL-17 family cytokines. Trends Immunol. 2012, 33:343-349.
41. Parker D., Prince A. Type I interferon response to extracellular bacteria in the airway epithelium. Trends Immunol. 2011, 32:582-588.
42. Rosenberg H.F., Domachowske J.B. Pneumonia virus of mice. severe respiratory infection in a natural host. Immunol. Lett. 2008, 118:6-12.
43. Rosenberg H.F., Domachowske J.B. Inflammatory responses to Respiratory Syncytial Virus (RSV) infection and the development of immunomodulatory pharmacotherapeutics. Curr. Med. Chem. 2012, 19:1424-1431.
44. Shadman K.A., Wald E.R. A review of paluvizumab and emerging therapies for respiratory syncytial virus. Expert Opin. Biol. Ther. 2011, 11:1455-1467.
45. Sorbara M.T., Philpott D.J. Peptidoglycan: a critical activator of the mammalian immune system during infection and homeostasis. Immunol. Rev. 2011, 243:40-60.
46. Steinberg B.E., Goldenberg N.M., Lee W.L. Do viral infections mimic bacterial sepsis? The role of microvascular permeability: a review of mechanisms and methods. Antiviral Res. 2012, 93:2-15.
47. Strober W., Murray P.J., Kitani A., Watanabe T. Signalling pathways and molecular interactions of NOD1 and NOD2. Nature Rev. Immunol. 2006, 6:9-20.
48. Tate M.D., Ioannidis L.J., Croker B., Brown L.E., Brooks A.G., Reading P.C. The role of neutrophils during mild and severe influenza infections of mice. PLoS One 2011, 6(3):e17618.
49. Theivanthiran B., Batra S., Balamayooran G., Cai S., Kobayashi K., Flavell R.A., Jeyaseelan S. NOD2 signaling contributes to host defense in the lungs against Escherichia coli infection. Infect. Immun. 2012, 80:2558-2569.
50. Tregoning J.S., Schwarze J. Respiratory viral infections in infants: causes, clinical symptoms, virology, and immunology. Clin. Microbiol. Rev. 2010, 23:74-98.
51. Tuvim M.J., Evans S.E., Clement C.G., Dickey B.F., Gilbert B.E. Augmented lung inflammation protects against influenza pneumonia. PLoS One 2009, 4(1):e4176.
52. Welliver T.P., Reed J.L., Welliver R.C. Respiratory syncytial virus and influenza infections Observations from tissues of fatal infant cases. Pediatr. Infect. Dis. J. 2008, 27:S92-S96.
53. Williams A.E., Edwards L., Humphreys I.R., Snelgrove R., Rae A., Rappuoli R., Hussell T. Innate imprinting by the modified heat-labile toxin of Escherichia coli (LTK63) provides generic protection against lung infectious disease. J. Immunol. 2004, 173:7435-7443.
54. Wright M., Piedimonte G. Respiratory syncytial virus prevention and therapy: past, present, and future. Pediatr. Pulmonol. 2011, 46:324-347.
55. Young H.N., Lee D.H., Lee Y.N., Park J.K., Yuk S.S., Yang S.Y., Lee H.J., Woo S.H., Kim H.M., Lee J.B., Park S.Y., Choi I.S., Song C.S. Intranasal administration of live Lactobacillus species facilitates protection against influenza virus infection in mice. Antiviral Res. 2012, 93:138-143.